《BioRxiv,3月14日,A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-15
  • A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

    Meng Yuan, Nicholas C. Wu, Xueyong Zhu, Chang-Chun D. Lee, Ray T. Y. So, Huibin Lv, Chris K. P. Mok, Ian A. Wilson

    doi: https://doi.org/10.1101/2020.03.13.991570

    Abstract

    The outbreak of COVID-19, which is caused by SARS-CoV-2 virus, continues to spread globally, but there is currently very little understanding of the epitopes on the virus. In this study, we have determined the crystal structure of the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein in complex with CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient. CR3022 targets a highly conserved epitope that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding site can only be accessed when at least two RBDs on the trimeric S protein are in the ″up″ conformation. Overall, this study provides structural and molecular insight into the antigenicity of SARS-CoV-2.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.biorxiv.org/content/10.1101/2020.03.13.991570v1
相关报告
  • 《BioRxiv,3月14日,Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-15
    • Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights Ilda D'Annessa, Filippo Marchetti, Giorgio Colombo doi: https://doi.org/10.1101/2020.03.13.990267 Abstract The appearance of the novel betacoronavirus SARS-CoV-2 represents a major threat to human health, and its diffusion around the world is causing dramatic consequences. The knowledge of the 3D structures of SARS-CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules. Specifically, comparative analyses of the structures of SARS-CoV-2 proteins and homologous proteins from previously characterized viruses, such as SARS-CoV, can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《3月14日_SARS-CoV-2和SARS-CoV受体结合域中有高度保守的抗原决定簇》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-15
    • 信息名称:SARS-CoV-2和SARS-CoV受体结合域中有高度保守的抗原决定簇 1.时间:2020年3月14日 2.机构或团队:美国斯克里普斯研究所、香港大学李嘉诚医学院 3.事件概要: 美国斯克里普斯研究所和香港大学李嘉诚医学院的科研人员在bioRxiv预印版平台发表论文“A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV”,旨在研究SARS-CoV-2的抗原性结构和分子结构。 文章指出,由SARS-CoV-2病毒引起的COVID-19爆发继续在全球蔓延,但目前对该病毒的表位了解甚少。在这项研究中,科研人员已经确定了SARS-CoV-2刺突蛋白与CR3022复合体的受体结合域(RBD)的晶体结构,CR3022是先前从恢复期SARS患者中分离出的中和抗体。CR3022靶向高度保守的表位,使SARS-CoV-2和SARS-CoV之间发生交叉反应结合。结构建模进一步证明,只有当三聚体S蛋白上的至少两个RBD处于“up”构象时,才能靠近结合位点。总体而言,这项研究对SARS-CoV-2的抗原性结构和分子结构方面加深了了解。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用. 4.附件: 原文链接: https://www.biorxiv.org/content/10.1101/2020.03.13.991570v1